Research Gaps in Primary Pediatric Hypertension.
Adolescent
Biomedical Research
/ methods
Blood Pressure Monitoring, Ambulatory
/ methods
Child
Child, Preschool
Education
/ methods
Female
Humans
Hypertension
/ diagnosis
Infant
Male
National Heart, Lung, and Blood Institute (U.S.)
/ trends
National Institute of Child Health and Human Development (U.S.)
/ trends
United States
/ epidemiology
Journal
Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
accepted:
11
02
2019
pubmed:
27
4
2019
medline:
15
11
2019
entrez:
27
4
2019
Statut:
ppublish
Résumé
Hypertension affects >40% of the US population and is a major contributor to cardiovascular-related morbidity and mortality. Although less common among children and adolescents, hypertension affects 1% to 5% of all youth. The 2017 Clinical Practice Guideline for the Diagnosis and Management of High Blood Pressure in Children and Adolescents provided updates and strategies regarding the diagnosis and management of hypertension in youth. Despite this important information, many gaps in knowledge remain, such as the etiology, prevalence, and trends of hypertension; the utility and practicality of ambulatory blood pressure monitoring; practical goals for lifestyle modification that are generalizable; the long-term end-organ impacts of hypertension in youth; and the long-term safety and efficacy of antihypertensive therapy in youth. The
Identifiants
pubmed: 31023830
pii: peds.2018-3517
doi: 10.1542/peds.2018-3517
pmc: PMC6564054
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2019 by the American Academy of Pediatrics.
Déclaration de conflit d'intérêts
POTENTIAL CONFLICT OF INTEREST: Dr Baker-Smith was the methodologist and epidemiologist for the 2017 Clinical Practice Guideline for the Diagnosis and Management of High Blood Pressure in Children and Adolescents; Dr Daniels has served as a consultant for Sanofi and is the chair of a data monitoring and safety committee for Novo Nordisk; the other authors have indicated they have no potential conflicts of interest to disclose.
Références
Hypertension. 2008 Apr;51(4):829-33
pubmed: 18285612
J Hypertens. 2007 Nov;25(11):2209-17
pubmed: 17921814
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
Pediatrics. 2017 Sep;140(3):
pubmed: 28827377
JAMA. 2007 Aug 22;298(8):874-9
pubmed: 17712071
Clin Pediatr (Phila). 2010 Oct;49(10):938-46
pubmed: 20724342
J Pediatr. 2010 Sep;157(3):461-7, 467.e1-5
pubmed: 20488454
J Clin Hypertens (Greenwich). 2011 Oct;13(10):758-66
pubmed: 21974764
Hypertension. 2015 Dec;66(6):1108-15
pubmed: 26558818
J Pediatr. 2010 Aug;157(2):282-7
pubmed: 20400095
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
pubmed: 15286277
J Hypertens. 2010 May;28(5):1083-90
pubmed: 20160654
J Clin Pharmacol. 2003 Feb;43(2):128-32
pubmed: 12616664
Clin J Am Soc Nephrol. 2018 Jun 7;13(6):874-883
pubmed: 29674338
J Clin Hypertens (Greenwich). 2011 May;13(5):332-42
pubmed: 21545394
Hypertension. 2004 Sep;44(3):289-93
pubmed: 15262902
Pediatr Nephrol. 2002 May;17(5):345-50
pubmed: 12042891
Hypertension. 2013 Aug;62(2):247-54
pubmed: 23856492
Hypertension. 2017 Oct;70(4):683-686
pubmed: 28827475
J Clin Hypertens (Greenwich). 2008 Oct;10(10):743-50
pubmed: 19090875
J Am Coll Cardiol. 1995 Apr;25(5):1056-62
pubmed: 7897116
J Pediatr. 2007 Feb;150(2):134-9, 139.e1
pubmed: 17236889
Hypertension. 2018 Sep;72(3):625-631
pubmed: 29987102
Pediatr Nephrol. 2007 Oct;22(10):1743-9
pubmed: 17680275
Am J Hypertens. 2003 Oct;16(10):795-800
pubmed: 14553956
J Pediatr. 2004 Sep;145(3):353-9
pubmed: 15343191
Pediatrics. 2013 Mar;131(3):490-525
pubmed: 23439904
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
Pediatrics. 1987 Jan;79(1):1-25
pubmed: 3797155
Am J Hypertens. 1995 Jul;8(7):657-65
pubmed: 7546488
Pediatrics. 2016 Dec;138(6):
pubmed: 27940711
J Am Diet Assoc. 2008 Feb;108(2):276-86; discussion 286
pubmed: 18237576
J Hypertens. 2011 Dec;29(12):2484-90
pubmed: 22025233
N Engl J Med. 2015 Oct;373(14):1307-17
pubmed: 26422721
J Clin Hypertens (Greenwich). 2011 May;13(5):357-65
pubmed: 21545397
J Pediatr. 2003 Dec;143(6):720-4
pubmed: 14657815
Acta Paediatr. 2018 Jan;107(1):14-19
pubmed: 28986990
J Clin Pharmacol. 2002 Aug;42(8):870-80
pubmed: 12162469
Pediatr Nephrol. 2007 Feb;22(2):249-57
pubmed: 17053885
J Pediatr. 2007 Jun;150(6):640-4, 644.e1
pubmed: 17517252
Hypertension. 2010 Jun;55(6):1323-30
pubmed: 20385971
Blood Press Monit. 2017 Feb;22(1):48-50
pubmed: 27824679
Pediatrics. 2007 Mar;119(3):544-53
pubmed: 17332208
Circulation. 1998 May 19;97(19):1907-11
pubmed: 9609083
Hypertension. 2008 Aug;52(2):222-8
pubmed: 18591457
J Clin Pharmacol. 2001 Jul;41(7):742-9
pubmed: 11452706
Pediatr Nephrol. 2003 Jun;18(6):548-53
pubmed: 12700955
Am J Hypertens. 2005 Feb;18(2 Pt 1):183-90
pubmed: 15752945
J Pediatr. 2017 Jan;180:148-155.e1
pubmed: 27692987
Hypertension. 2018 Mar;71(3):444-450
pubmed: 29295853